4//SEC Filing
Lee Gary K. 4
Accession 0001209191-22-009580
CIK 0001806952other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 8:59 PM ET
Size
5.4 KB
Accession
0001209191-22-009580
Insider Transaction Report
Form 4
Lee Gary K.
Chief Scientific Officer
Transactions
- Award
Option (right to buy)
2022-02-11+800,000→ 800,000 totalExercise: $6.04Exp: 2032-02-10→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]1/4 of the option shares shall vest on January 31, 2023, with the remaining option shares to vest in equal monthly installments over the following thirty-six months.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001907345
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 8:59 PM ET
- Size
- 5.4 KB